Archives: Speakers

Peter Mintjens, Sr. Business Development & account Manager for SABIC’s Specialties business, with dedicated responsibility for Mass transportation covering Aerospace and train market. Working for 35 years within the plastic industry covering full range of thermoplastic polymers with a background into processing. Since 2011 covering SABIC’s engineering plastics product range for several industries.

Application Engineer for the industrial sector at SAERTEX GmbH & Co. KG – worldwide manufacturer of NCFs made of glass, carbon, aramid and natural fibers with headquarter in Germany. Strong background in the design and production of composite parts.

Liam is a Project Officer at Transport Canada’s Innovation Centre, Rail and Aviation Research, Development, and Deployment (RD&D) group. Liam manages projects related to alternative fuel technologies in rail, as well as those aimed at addressing the impacts of climate change in the railway environment. 

Liam has been supporting the development of hydrogen and battery locomotive codes and standards in North America. He is currently working with CSA Group to revise existing CSA TS-601 (Hydrogen fuel cell locomotive) and 602 (Onboard lithium-ion battery locomotive) technical specifications. These specifications were initially published in the 2022/2023 fiscal year but have been opened again to investigate newly-identified risk scenarios, including operation in tunnels, battery crashworthiness, and shock and vibration. The next editions of the specifications will also look to incorporate new data and information from active hydrogen technology trials in North America, and ensure alignment with emerging international standards. 

On the climate change adaptation side, Liam has supported projects aimed at reducing wildfire risk impacts to railways in Canada. He is currently involved in drafting a wildfire best practice guide for monitoring and managing risks to railways. Additionally, Liam manages a railway fire risk task team which provides an open forum between government and North American railway companies to share updates from their current and planned wildfire mitigation projects, discuss railway fire management plans, and identify opportunities for collaboration. 

Ana is a Senior Solution Consultant at Medidata, specializing in Clinical Data Studio, working with clients on their clinical data management and study conduct strategies. Ana has a Masters in Neurobiology and 10 years of experience in SaaS technology, with the last 5 years focused on clinical trial technologies

I thrive on communication. This theme runs through everything I do, including running multi-national clinical program teams, maximizing the use of information technology in both my business and personal life, and passionately seeking out new ideas and information to share with others. My background in medical research has given me the tools necessary to succeed in the field of clinical operations, while my skills and interest in technology continue to drive me towards new ways to connect and interact with others.

As we move into a new era of drug development, I am increasingly interested in leveraging technology to streamline and decentralizalize clinical trials. This includes wearable devices, remote monitoring, EMR access, and solutions in digital health.

Some specifics about me:

• Over 20 years expertise in Clinical Program Management and Operations at Pharma, Biotech, CRO, and Service Providers.
• Demonstrated success in hands-on problem solving and decision-making.
• Successful management of complex national and international Phase I through IV clinical trials and registries.
• Experienced in managing NDA and BLA preparation.
• Proven analytical skills in process development, technology integration, and training.
• Experienced in protocol development and review, budgeting, and time management.
• In-depth knowledge of Internet research resources and web interfaces.
• Highly proficient at Microsoft Office Suite, including Outlook, Excel, Word, and PowerPoint.
• Strong leadership, interpersonal, communication, and presentation skills, with supportive attitude.
• Bilingual in English and French.

Specialties: Phase I to IV clinical trials in multiple therapeutic areas, Patient Registries, Study Protocol Development, EDC (Electronic Data Capture), IVR (Interactive Voice Response), IST (Investigator Sponsored Trials), TMF (Trial Master Files), SOP development and process improvement, Budget Management, Software Training, Web Research, Broad Technical Knowledge.

With a background in television news, having anchored for Sky and produced / reported for other global networks including CNN, Bloomberg and CNBC, Sasha is a seasoned presenter and interviewer. She works across industries at the intersection of business, finance and technology. Sasha has facilitated many conversations on adopting and leveraging AI and tech transformation more broadly, frequently interviewing senior leaders from HPE to IBM and Microsoft amongst others.

Recent interviews include the Former Chancellor Philip Hammond, leading AI expert Mo Gawdat, the CEO of Strava, Mike Martin, the Head of GCHQ, Anne Keast-Butler and many more in the world of business and technology.

Events throughout 2024 included co-hosting at London Tech Week, emceeing at Money 20/20 in Europe, chairing the Innovate Finance Global Summit, and consumer technology event Leap, where Sasha was one of the main stage moderators. Other events include Connected Britain, Retail Week Live, The Next Web, The Financial Times Global Insurance Summit and The London Gatwick Economic Summit.

Sasha started her career in investment banking, and frequently works with financial institutions. She also spent several years as a Senior Programming Director at Bloomberg Live, where she curated and moderated flagship business and technology events. Sasha studied Social and Political Sciences at Cambridge University and spent her gap year studying at The Sorbonne.

David Goode is the Head of Workpapers Solutions at Inflo, where he leads the advancement of innovative tools that transform audit practices. A Chartered Accountant (ICAEW ACA) with over a decade of experience, David specializes in audit technology, data-driven methodologies, and practice management. Since joining Inflo in 2022 from Haysmacintyre, he has leveraged his expertise to support firms in successfully implementing Inflo’s solutions, while championing feedback-driven product improvements. Passionate about enhancing audit quality and efficiency, David is dedicated to empowering firms with cutting-edge technology and delivering lasting value to clients and teams alike.

Accomplished leader with 20+ yrs. of clinical trial experience in oncology, respiratory, and metabolic diseases. Industry expert, consistently delivering programs with high integrity. Adept at influencing stakeholders. Spearheads innovation. Passionate about transforming patient and caregiver experience in clinical trials.A Diversity, Equity and Belonging champion- founder of inclusive research group in Phase I oncology trials at AbbVie and creator of affinity groups within the community.
A suitcase-loathing adventurer. A Tiny Human’s Personal Assistant.

Ronen Mansuri currently serves as a Senior Biometrics Consultant, working for various Biotech companies in Israel including NeuroDerm, a clinical stage biotech company developing next-generation drug-device combination solutions for central nervous system disorders through proprietary drug formulations.

Prior to this Mr. Mansuri served as VP Clinical Operations & Biometrics at Galmed Pharmaceuticals and Senior Director, Head of Global Clinical Data Programming at Teva Pharmaceuticals. Ronen has vast experience in the Clinical Data Management and Statistical Programming areas for more than 20 years.

Mr. Ronen Mansuri is a PhD candidate in Personalized Medicine & Big Data Analytics in Tel Aviv University.